These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25544560)

  • 1. Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease.
    Raththagala M; Brewer MK; Parker MW; Sherwood AR; Wong BK; Hsu S; Bridges TM; Paasch BC; Hellman LM; Husodo S; Meekins DA; Taylor AO; Turner BD; Auger KD; Dukhande VV; Chakravarthy S; Sanz P; Woods VL; Li S; Vander Kooi CW; Gentry MS
    Mol Cell; 2015 Jan; 57(2):261-72. PubMed ID: 25544560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation.
    Fernández-Sánchez ME; Criado-García O; Heath KE; García-Fojeda B; Medraño-Fernández I; Gomez-Garre P; Sanz P; Serratosa JM; Rodríguez de Córdoba S
    Hum Mol Genet; 2003 Dec; 12(23):3161-71. PubMed ID: 14532330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biophysical characterization of laforin-carbohydrate interaction.
    Dias DM; Furtado J; Wasielewski E; Cruz R; Costello B; Cole L; Faria TQ; Baaske P; Brito RM; Ciulli A; Simões I; Macedo-Ribeiro S; Faro C; Geraldes CF; Castanheira P
    Biochem J; 2016 Feb; 473(3):335-45. PubMed ID: 26578817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lafora disease offers a unique window into neuronal glycogen metabolism.
    Gentry MS; Guinovart JJ; Minassian BA; Roach PJ; Serratosa JM
    J Biol Chem; 2018 May; 293(19):7117-7125. PubMed ID: 29483193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease.
    Nitschke F; Sullivan MA; Wang P; Zhao X; Chown EE; Perri AM; Israelian L; Juana-López L; Bovolenta P; Rodríguez de Córdoba S; Steup M; Minassian BA
    EMBO Mol Med; 2017 Jul; 9(7):906-917. PubMed ID: 28536304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired malin expression and interaction with partner proteins in Lafora disease.
    Skurat AV; Segvich DM; Contreras CJ; Hu YC; Hurley TD; DePaoli-Roach AA; Roach PJ
    J Biol Chem; 2024 May; 300(5):107271. PubMed ID: 38588813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimeric quaternary structure of human laforin.
    Sankhala RS; Koksal AC; Ho L; Nitschke F; Minassian BA; Cingolani G
    J Biol Chem; 2015 Feb; 290(8):4552-4559. PubMed ID: 25538239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of a laforin nanobody inhibitor.
    Simmons ZR; Sharma S; Wayne J; Li S; Vander Kooi CW; Gentry MS
    Clin Biochem; 2021 Jul; 93():80-89. PubMed ID: 33831386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laforin prevents stress-induced polyglucosan body formation and Lafora disease progression in neurons.
    Wang Y; Ma K; Wang P; Baba O; Zhang H; Parent JM; Zheng P; Liu Y; Minassian BA; Liu Y
    Mol Neurobiol; 2013 Aug; 48(1):49-61. PubMed ID: 23546741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle glycogen remodeling and glycogen phosphate metabolism following exhaustive exercise of wild type and laforin knockout mice.
    Irimia JM; Tagliabracci VS; Meyer CM; Segvich DM; DePaoli-Roach AA; Roach PJ
    J Biol Chem; 2015 Sep; 290(37):22686-98. PubMed ID: 26216881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan.
    Sullivan MA; Nitschke S; Steup M; Minassian BA; Nitschke F
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy.
    Chan EM; Ackerley CA; Lohi H; Ianzano L; Cortez MA; Shannon P; Scherer SW; Minassian BA
    Hum Mol Genet; 2004 Jun; 13(11):1117-29. PubMed ID: 15102711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway.
    Solaz-Fuster MC; Gimeno-Alcañiz JV; Ros S; Fernandez-Sanchez ME; Garcia-Fojeda B; Criado Garcia O; Vilchez D; Dominguez J; Garcia-Rocha M; Sanchez-Piris M; Aguado C; Knecht E; Serratosa J; Guinovart JJ; Sanz P; Rodriguez de Córdoba S
    Hum Mol Genet; 2008 Mar; 17(5):667-78. PubMed ID: 18029386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the role of malin in the lafora progressive myoclonus epilepsy.
    Romá-Mateo C; Sanz P; Gentry MS
    IUBMB Life; 2012 Oct; 64(10):801-8. PubMed ID: 22815132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease.
    Tiberia E; Turnbull J; Wang T; Ruggieri A; Zhao XC; Pencea N; Israelian J; Wang Y; Ackerley CA; Wang P; Liu Y; Minassian BA
    J Biol Chem; 2012 Jul; 287(30):25650-9. PubMed ID: 22669944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the structural insights on human laforin mutation K87A in Lafora disease--a molecular dynamics study.
    Srikumar PS; Rohini K
    Appl Biochem Biotechnol; 2013 Oct; 171(4):874-82. PubMed ID: 23904258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the Biological Activity of the Glucan Phosphatase Laforin.
    Romá-Mateo C; Raththagala M; Gentry MS; Sanz P
    Methods Mol Biol; 2016; 1447():107-19. PubMed ID: 27514803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phosphatase laforin crosses evolutionary boundaries and links carbohydrate metabolism to neuronal disease.
    Gentry MS; Dowen RH; Worby CA; Mattoo S; Ecker JR; Dixon JE
    J Cell Biol; 2007 Jul; 178(3):477-88. PubMed ID: 17646401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy.
    Mitra S; Chen B; Wang P; Chown EE; Dear M; Guisso DR; Mariam U; Wu J; Gumusgoz E; Minassian BA
    Dis Model Mech; 2023 Jan; 16(1):. PubMed ID: 36511140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphatase activity of laforin is dispensable to rescue Epm2a-/- mice from Lafora disease.
    Gayarre J; Duran-Trío L; Criado Garcia O; Aguado C; Juana-López L; Crespo I; Knecht E; Bovolenta P; Rodríguez de Córdoba S
    Brain; 2014 Mar; 137(Pt 3):806-18. PubMed ID: 24430976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.